

Retatrutide
GLP-1 Peptide · 5mg~40mg

SSRBIO specializes in high-purity peptide manufacturing, GLP-1 research compounds, and global fulfillment. Leveraging years of international logistics experience and comprehensive export documentation, SSRBIO delivers research products worldwide with a customer-first delivery guarantee, including complimentary reshipment or a full refund for eligible undelivered orders.
Retatrutide wholesale supplier listing
Product overview
Retatrutide wholesale listing from SSRBIO offering configurable 5mg to 40mg research vial options for metabolic and GLP-1 peptide research applications. Includes public Janoshik batch verification references, MOQ export ordering, tracked China dispatch fulfilment, and international supplier shipping support.
SSRBIO
Shipping lanes
Tracking information is provided once the order has shipped.
Retatrutide
Overview
Retatrutide is an investigational synthetic peptide designed as a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways. It is one of the most closely watched metabolic research compounds because it combines three incretin and energy-balance signalling pathways in a single molecule.
Molecular Class
Synthetic peptide / incretin-based triple hormone receptor agonist.
Mechanism
Retatrutide is designed to activate glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor pathways. This combined receptor profile makes it different from single GLP-1 agonists and dual GIP/GLP-1 agonists.
Research Areas
- Obesity research
- Metabolic signalling research
- Type 2 diabetes research
- Liver-fat and MASLD research
- Appetite and satiety pathway research
- Cardiovascular risk-factor research
- Energy expenditure research
- Incretin pharmacology research
Research Status
Retatrutide remains an investigational compound in active clinical development. Lilly is studying it across several Phase 3 programs, including obesity, type 2 diabetes, sleep apnea, osteoarthritis, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease.
Market Demand
Global demand is driven by obesity, metabolic disease, GLP-1, and next-generation incretin research. China-based peptide manufacturers frequently list retatrutide in wholesale vial formats for international research buyers.
Retatrutide supplier questions
What is Retatrutide?
Retatrutide is a glp-1 peptide supplied by SSRBIO, featuring public Janoshik-linked batch testing references, 5mg~40mg vial configurations, and China fulfilment support for research-use laboratory workflows.
What MG configurations are available for Retatrutide?
Retatrutide is available in 5mg~40mg configurations depending on SSRBIO inventory availability and supplier stock levels.
Has Retatrutide undergone batch testing?
SSRBIO is a peptide supplier operating from China, offering Retatrutide batches with public laboratory testing references and international fulfilment support.
Who supplies this Retatrutide?
SSRBIO is a China-based peptide supplier offering Retatrutide batches with public laboratory testing references and international fulfilment support.
What is the MOQ for Retatrutide?
The current minimum order quantity for Retatrutide is 10 vials / 1 box.
Is Retatrutide intended for human use?
Retatrutide is supplied strictly for laboratory research use only and is not sold for human consumption, medical use, or self-administration.



